Advances for Immunotherapy in Prostate Cancer

Session 6:  Advances for Immunotherapy in Prostate Cancer 

12:20 PM  1:15 PM

Moderator:
Howard Soule, PhD
Prostate Cancer Foundation

Introduction
Howard Soule, PhD
Prostate Cancer Foundation

Clinical Development of PSCA-Targeted CAR T Cells for Advanced Prostate Cancer
Tanya Dorff, MD
City of Hope

Co-expression of a Novel TGFβR Dominant Negative Receptor to Enhance PSMA Chimeric Antigen Receptor Therapy in the Treatment of Castrate Resistant Prostate Cancer Patients
Naomi Haas, MD
University of Pennsylvania

82 cents of every dollar donated goes to our prostate cancer research mission

Join the fight against prostate cancer today. Donate